• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口咽癌颈淋巴结转移的分布:对N0颈部的治疗意义

Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.

作者信息

Lim Young Chang, Koo Bon Seok, Lee Jin Seok, Lim Jae-Yol, Choi Eun Chang

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Konkuk University College of Medicine, Seoul, Korea.

出版信息

Laryngoscope. 2006 Jul;116(7):1148-52. doi: 10.1097/01.mlg.0000217543.40027.1d.

DOI:10.1097/01.mlg.0000217543.40027.1d
PMID:16826050
Abstract

OBJECTIVES

This study sought to investigate the patterns and distributions of lymph node metastases in oropharyngeal squamous cell carcinoma (SCC) and improve the rationale for elective treatment of N0 neck.

MATERIALS AND METHODS

One hundred four patients with oropharyngeal SCC who underwent neck dissection between 1992 and 2003 were analyzed retrospectively. All patients had curative surgery as their initial treatment for the primary tumor and neck. A total of 161 neck dissections on both sides of the neck were performed. Therapeutic dissections were done in 71 and 5 necks and elective neck dissection was done on 33 and 52 necks on the ipsilateral and contralateral sides, respectively. Surgical treatment was followed by postoperative radiotherapy for 78 patients. The follow-up period ranged from 1 to 96 months (mean, 30 months).

RESULTS

Of the 161 neck dissection specimens evaluated, 90 (56%) necks were found to have lymph node metastases found by pathologic examination. These consisted of 76 (73% of 104 necks) of the ipsilateral side and 14 (25% of 57 necks) of the contralateral side dissections. The occult metastatic rate was 24% (8 of 33) of ipsilateral neck samples and 21% (11 of 52) of contralateral neck samples. Of the 68 patients who had a therapeutic dissection on the ipsilateral side and had lymphatic metastasis, the incidence rate of level IV and level I metastasis was 37% (25 of 68) and 10% (7 of 68), respectively. Isolated metastasis to level IV occurred on the ipsilateral side in three patients. There were no cases of isolated ipsilateral level I pathologic involvement in an N-positive neck or occult metastasis to this group. The incidence rate of level IV metastasis in patients with ipsilateral nodal metastasis was significantly higher in base of tongue cancer (86% [6 of 7]) compared with tonsillar cancer (34% [20 of 59]) (P=.013). Patients with level IV metastasis had significantly worse 5-year disease-free survival rates than patients with metastasis to other neck levels (54% versus 71%; P=.04).

CONCLUSION

These results suggest that elective N0 neck treatment in patients with oropharyngeal SCC, especially base of tongue cancer, should include neck levels II, III, and IV instead of levels I, II, and III.

摘要

目的

本研究旨在调查口咽鳞状细胞癌(SCC)中淋巴结转移的模式和分布情况,并完善对N0颈部进行选择性治疗的理论依据。

材料与方法

对1992年至2003年间接受颈部清扫术的104例口咽SCC患者进行回顾性分析。所有患者均以根治性手术作为原发肿瘤和颈部的初始治疗。共对双侧颈部进行了161次颈部清扫。71例和5例颈部进行了治疗性清扫,同侧和对侧分别有33例和52例颈部进行了选择性颈部清扫。78例患者术后接受了放疗。随访时间为1至96个月(平均30个月)。

结果

在评估的161份颈部清扫标本中,病理检查发现90例(56%)颈部有淋巴结转移。其中包括同侧76例(104例颈部中的73%)和对侧14例(57例颈部中的25%)清扫标本。同侧颈部标本的隐匿转移率为24%(33例中的8例),对侧颈部标本为21%(52例中的11例)。在同侧进行治疗性清扫且有淋巴转移的68例患者中,IV区和I区转移的发生率分别为37%(68例中的25例)和10%(68例中的7例)。有3例患者同侧出现孤立性IV区转移。在N阳性颈部中,没有同侧I区病理单独受累或该组隐匿转移的病例。舌根癌患者同侧淋巴结转移时IV区转移的发生率(86% [7例中的6例])显著高于扁桃体癌患者(34% [59例中的20例])(P = 0.013)。IV区转移患者的5年无病生存率显著低于转移至其他颈部区域的患者(54%对71%;P = 0.04)。

结论

这些结果表明,口咽SCC患者,尤其是舌根癌患者,N0颈部的选择性治疗应包括II、III和IV区,而非I、II和III区。

相似文献

1
Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.口咽癌颈淋巴结转移的分布:对N0颈部的治疗意义
Laryngoscope. 2006 Jul;116(7):1148-52. doi: 10.1097/01.mlg.0000217543.40027.1d.
2
Management of contralateral N0 neck in pyriform sinus carcinoma.梨状窦癌对侧N0颈部的处理
Laryngoscope. 2006 Jul;116(7):1268-72. doi: 10.1097/01.mlg.0000225936.88411.71.
3
Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.早期舌癌对侧N0颈部的治疗:选择性颈部清扫术与观察对比
Laryngoscope. 2006 Mar;116(3):461-5. doi: 10.1097/01.mlg.0000195366.91395.9b.
4
Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?临床颈部淋巴结阳性的口腔和口咽癌患者行Ⅴ区淋巴结清扫术:是否绝对必要?
Laryngoscope. 2006 Jul;116(7):1232-5. doi: 10.1097/01.mlg.0000224363.04459.8b.
5
Management of contralateral N0 neck in tonsillar squamous cell carcinoma.扁桃体鳞状细胞癌对侧N0颈部的处理
Laryngoscope. 2005 Sep;115(9):1672-5. doi: 10.1097/01.mlg.0000184791.68804.0b.
6
Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma.口咽鳞状细胞癌择期颈部清扫术中的IIb级淋巴结转移
Oral Oncol. 2006 Nov;42(10):1017-21. doi: 10.1016/j.oraloncology.2005.12.023. Epub 2006 Jun 6.
7
Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?对于临床N0期喉癌的选择性侧颈清扫术,IV区的解剖是绝对必要的吗?
Oral Oncol. 2006 Jan;42(1):102-7. doi: 10.1016/j.oraloncology.2005.06.019. Epub 2005 Sep 6.
8
Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.喉鳞状细胞癌的IIb级淋巴结转移
Laryngoscope. 2006 Feb;116(2):268-72. doi: 10.1097/01.mlg.0000197314.78549.d8.
9
[Squamous-cell carcinoma of the tongue: treatment results and prognosis].[舌鳞状细胞癌:治疗结果与预后]
Rev Stomatol Chir Maxillofac. 2003 Feb;104(1):10-7.
10
Management of contralateral N0 neck in oral cavity squamous cell carcinoma.口腔鳞状细胞癌对侧N0颈部的处理
Head Neck. 2006 Oct;28(10):896-901. doi: 10.1002/hed.20423.

引用本文的文献

1
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.口咽癌和下咽癌基于证据的诊断、治疗、预防及术后护理指南
Ger Med Sci. 2025 Jun 24;23:Doc03. doi: 10.3205/000339. eCollection 2025.
2
Squamous cell carcinoma metastatic to the lymph nodes of the parapharyngeal space: case series and systematic review.鳞状细胞癌转移至咽旁间隙淋巴结:病例系列和系统评价。
Acta Otorhinolaryngol Ital. 2024 Aug;44(4):223-232. doi: 10.14639/0392-100X-N2993.
3
Unilateral Neck Treatment with either Surgery and/or Radiotherapy for Squamous Cell Carcinoma for the Tonsil.
扁桃体鳞状细胞癌的单侧颈部手术和/或放疗治疗
ORL J Otorhinolaryngol Relat Spec. 2024;86(3-4):140-150. doi: 10.1159/000541390. Epub 2024 Sep 12.
4
Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.Pre-CCRT 18-氟脱氧葡萄糖 PET-CT 通过准确的放疗计划改善 p16 阴性局部晚期口咽鳞癌患者的生存。
J Otolaryngol Head Neck Surg. 2023 Feb 13;52(1):14. doi: 10.1186/s40463-023-00623-y.
5
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.免疫治疗时代的头颈部癌症治疗:2023 年更新。
Drugs. 2023 Feb;83(3):217-248. doi: 10.1007/s40265-023-01835-2. Epub 2023 Jan 16.
6
Perifacial Lymph Node Metastasis After Treatment of Oropharyngeal Primary Malignancy: A Case Report.口咽原发性恶性肿瘤治疗后面部周围淋巴结转移:一例报告
Cureus. 2022 Nov 10;14(11):e31332. doi: 10.7759/cureus.31332. eCollection 2022 Nov.
7
Rate of atypical nodal metastases in surgically treated HPV-associated oropharyngeal squamous cell carcinoma.手术治疗 HPV 相关口咽鳞癌的非典型性淋巴结转移率。
Head Neck. 2023 Feb;45(2):409-416. doi: 10.1002/hed.27256. Epub 2022 Nov 23.
8
Prediction of Occult Contralateral Nodal Metastasis in Surgical Treated p16 Negative Oropharyngeal Squamous Cell Carcinoma.手术治疗的p16阴性口咽鳞状细胞癌隐匿性对侧淋巴结转移的预测
Cancer Manag Res. 2022 Nov 10;14:3151-3158. doi: 10.2147/CMAR.S382394. eCollection 2022.
9
Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review.早期(Ⅰ期和Ⅱ期)口咽癌的治疗选择:叙述性综述。
Medicina (Kaunas). 2022 Aug 4;58(8):1050. doi: 10.3390/medicina58081050.
10
Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.cN0HPV 阴性口咽鳞癌行 IV 区颈部清扫术:一项回顾性队列研究。
BMC Cancer. 2022 May 12;22(1):535. doi: 10.1186/s12885-022-09609-x.